Small Cap Stocks | Investors Alley
Archive | Small Cap Stocks RSS feed for this section

4 Triple-Digit Winners in Biotech

With important catalysts coming up in 2017, these stocks could soon become triple-digit winners in your portfolio. Start building a well-diversified biotech portfolio with these four stocks.  The overall biotech sector continues to be locked in a tight trading range, especially for such a high beta sector of the market. First quarter earnings reports for […]

Read more

3 Small Biotech Stocks for Massive Gains

With the biotech sector still waiting for M&A to pick up, investors should turn to these three stocks that have great growth potential on the horizon. Their next catalysts are coming up soon and could send their prices up triple digits. The main biotech indices remain mired in the mud.  This high beta sector of […]

Read more

3 Small Cap Stocks for Apple-Like Returns

Imitating the amazing returns that Apple handed investors since it launched the iPhone is no easy task, but Bret Jensen thinks that these three stocks might be able to come close.  Don’t look now, but first quarter earnings seasons is coming up directly ahead. The first quarter for the market was largely a positive one […]

Read more

3 Undervalued Stocks on the Verge of a Breakout

Buying shares at these prices might look like a gift in six month’s time. With multiple catalysts to fuel share price growth on the horizon and a lot of good news not yet baked into the share price, now is a great time to get in.  The fairy tale story for biotech investors is buying […]

Read more

3 Stocks to Buy for a Decade of Gains

Get the insider tip on three stocks with red-hot growth that could top your portfolio gains for the next 10 years. Bret Jensen sees seven specific reasons why these stocks deserve a spot in your portfolio. The Trump administration is still trying to pivot from failing to repeal and replace the Affordable Health Care Act. […]

Read more

The 4 Types of Biotech Stocks: Which Should You Own?

Well, it certainly has not been a dull start for the biotech sector so far in 2017. After a punk year for M&A activity in 2016, we saw three large deals announced across the industry in January. This helped trigger a 10% surge in this area of the market in February. In March, we have […]

Read more

3 Small Biotech Moonshots to Add to Your Portfolio

As the biotech sector heats up more in 2017, small stocks like the three in this article have already turned in some stellar performances. With the entire sector gaining steam, there’s still plenty of upside left. Bret Jensen recommends adding these three stocks to the portfolio.  Sentiment on the biotech sector early in 2017 sure has […]

Read more

The Best Is yet to Come for These 5 Stocks

Having strong tailwinds pushing them higher, these five stocks should see a period of growth that extends for years, if not longer. Add some share price growth to your portfolio with any of these five stocks.  The market has experienced a heck of a ride since the unexpected election in November. Contrary to consensus opinion […]

Read more

3 Biotech Stock Beneficiaries of a Streamlined FDA

With lower approval wait times and decreased regulations on the horizon, long-term investing opportunities in the biotech sector haven’t looked this great in over two years. Take a look at these three stocks in particular as they will reap the most reward from a streamlined FDA.  After an approximate gain of 10% in February, the […]

Read more

3 Triple-Digit Winners in Biotech Revisited

After an especially great start to 2017, these three stocks that Bret Jensen has profiled often on these pages have shot up like rockets and now all have substantial triple-digit gains. Now’s the time to take some gains in these stocks if you followed along on Bret’s earlier recommendations.  The biotech sector has seen a […]

Read more